Alzheimer Disease/Dementia

>

Latest News

Donanemab Label Revised: New Dosing Schedule Approved for Early Alzheimer’s Treatment
Donanemab Label Revised: New Dosing Schedule Approved for Early Alzheimer’s Treatment

July 9th 2025

The FDA approved updated dosing for donanemab in early Alzheimer disease, reducing ARIA-E risk by 41% without compromising efficacy.

Quest Will Offer FDA-Cleared Fujirebio Blood Test to Detect Alzheimer Disease / image courtesy of Quest Diagnostics
Quest Will Offer FDA-Cleared Fujirebio Blood Test to Detect Alzheimer Disease

July 9th 2025

Mayo Clinic AI Tool Allows Rapid, Precise Identification of 9 Types of Dementia From Single Brain Scan / images courtesy of Mayo Clinic
Mayo Clinic AI Tool Allows Rapid, Precise Identification of 9 Types of Dementia From Single Brain Scan

July 1st 2025

 Adjuvanted Vaccines Against Shingles, RSV Associated with Reduced Risk of Dementia, New Study Shows
Adjuvanted Vaccine Against RSV Associated with Substantial Reduced Risk of Dementia

June 30th 2025

Only Half of Adults Adherent to Antidementia Medication Regimens at 1 Year: New Meta-Analysis Results / image credit ©Speedkings/Shutterstock.com
Only Half of Patients Adherent to Antidementia Medication Regimens at 1 Year: New Meta-Analysis Results

June 26th 2025

Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.